Use of 15-lipoxygenase inhibitors for treating obesity

Details Use of 15-lipoxygenase inhibitors for treating obesity Use of 15-lipoxygenase inhibitors for treating obesity

2008-07-30

2011-11-01

Weddington, Kevin E (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S342000, C514S909000

Reexamination Certificate

active

08048900

ABSTRACT:
The invention concerns the treatment of obesity, in particular abdominal visceral obesity. More specifically, the invention concerns the use of selective 15-lipoxygenase (LO) inhibitors for preparing medicines useful in the treatment of obesity, or at least abdominal visceral obesity, and/or its consequences.

REFERENCES:
patent: 5972980 (1999-10-01), Cornicelli et al.
patent: 7351727 (2008-04-01), Weinstein
patent: WO 97/12613 (1997-04-01), None
patent: WO 99/17761 (1999-04-01), None
patent: WO 2004/112695 (2004-12-01), None
patent: WO 2006/044556 (2006-04-01), None
patent: WO 2007/085775 (2007-08-01), None
Yokota et al., “Molecular biology and biochemistry of lipoxygenases and related pathways”, New Horizons in Biotechnology, [International Conference on New Horizons in Biotechnology], Trivandrum, India, Apr. 18-21, 2001 (2003), Meeting Date 2001, 199-214 (enclosed abstract).
Alberti, et al. (Sep. 24, 2005) “The metabolic syndrome—a new worldwide definition.” Lancet 366(9491): 1059-1062.
Bray, et al. (Apr. 6, 2000) “Medicinal strategies in the treatment of obesity.” Nature 404: 672-677.
Weinstein, et al. (Mar. 1, 2005) “Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.” Bioorganic & Medicinal Chemistry Letters 15(5): 1435-1440.
International Search Report dated Sep. 21, 2009 for International Application No. PCT/FR2007/050711.
Written Opinion dated Sep. 21, 2009 for International Application No. PCT/FR2007/050711.
Cornicelli JA et al, “15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease”, Curr Phram Des. Jan. 1999; 5(1);11-20 (PubMed Abstract).
Cichewicz et al, “Redox Inactivation of Human 15-Lipoxygenase by Marine-Derived Meroditerpenes and Synthetic Chromanes: Archetypes for a Unique Class of Selective and Recyclable Inhibitors”, J. Am. Chem. Soc. 2004, 126, 14910-14920.
Segraves et al, “Probing the Activity Differences of Simple and Complex Brominated Aryl Compounds against 15-soybean, 15-Human, and 12-Human Lipoxygenase”, J. Med. Chem. 2004, 47, 4060-4065.

Affiliated with

Also associated with

Rating

Use of 15-lipoxygenase inhibitors for treating obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 15-lipoxygenase inhibitors for treating obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 15-lipoxygenase inhibitors for treating obesity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4283669